Yue Shi

11.8k total citations · 1 hit paper
93 papers, 3.0k citations indexed

About

Yue Shi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yue Shi has authored 93 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 28 papers in Cancer Research and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yue Shi's work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (11 papers) and Epigenetics and DNA Methylation (9 papers). Yue Shi is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (11 papers) and Epigenetics and DNA Methylation (9 papers). Yue Shi collaborates with scholars based in China, United States and Australia. Yue Shi's co-authors include Michael Andreeff, Marina Konopleva, Zhihong Zeng, Weimin Ci, Xiaoyang Ling, Mark J. Levis, Rui-Yu Wang, Joshua B. Rubin, Elihu H. Estey and Sergej Konoplev and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Yue Shi

85 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multispecies forest plantations outyield monocultures across a broad range of conditions

2022 252 citations Yuhao Feng, Bernhard Schmid et al. Science profile →

Peers

Countries citing papers authored by Yue Shi

Since Specialization

Citations

This map shows the geographic impact of Yue Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Shi more than expected).

Fields of papers citing papers by Yue Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Shi. The network helps show where Yue Shi may publish in the future.

Co-authorship network of co-authors of Yue Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yue Shi. A scholar is included among the top collaborators of Yue Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue Shi. Yue Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring potential biosafety implications in DNA information storage 2025 ·Biosafety and Health ·(unknown), Yue Shi, Jing Yang, Haizhou Liu, Lijia Jia, Di Liu	0
2	Risk analysis and mediation analysis of stress hyperglycemia ratio and all-cause mortality in patients with acute kidney injury 2025 ·Diabetology & Metabolic Syndrome ·Yue Shi, (unknown), (unknown), Xiujie Shi, (unknown), (unknown)	0
3	Single‐Cell Analysis Reveals that Vitamin C Inhibits Bone Metastasis of Renal Cancer via Cell Cycle Arrest and Microenvironment Remodeling 2025 ·Advanced Science ·Jianye Zhang, Qi Zhang, (unknown), Ying Wang, Juan Li, Ping Wang, Jie Qi, Yuan Liang, Shiming He, Yanqing Gong, Ninghan Feng, Yang Wang, Yuanyuan Ma, Mei Zhang, Yue Shi, Xuesong Li, Weimin Ci, Liqun Zhou	1
4	Circadian rhythm disruption: a potential trigger in Parkinson’s disease pathogenesis 2024 ·Frontiers in Cellular Neuroscience ·Ke Xu, Yu Zhang, Yue Shi, (unknown), Chengguang Zhang, Tianjiao Wang, Peng Lv, Yan Bai, Shun Wang	3
5	A surface-independent bioglue using photo-crosslinkable benzophenone moiety 2024 ·RSC Advances ·Yue Shi, Xuelian Tao, Ping Du, (unknown), Lars Esser, Hsien‐Yeh Chen, Helmut Thissen, Peng‐Yuan Wang	3
6	A Missense Mutation c.1132G > A in Fumarate Hydratase (FH) Leads to Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) Syndrome and Insights into Clinical Management in Uterine Leiomyomata 2023 ·Genes ·Yue Shi, Yan Xu, Chao Wang, Yiqing Chen, Xiaojun Ren, Yu Kang	3
7	Mechanosensation by endothelial PIEZO1 is required for leukocyte diapedesis 2022 ·Blood ·Shengpeng Wang, Bianbian Wang, Yue Shi, (unknown), (unknown), Boris Strilić, Ting Li, (unknown), Changhe Wang, Nina Wettschureck, Dietmar Vestweber, Stefan Offermanns	69
8	Multispecies forest plantations outyield monocultures across a broad range of conditions breakdown → 2022 ·Science ·Yuhao Feng, Bernhard Schmid, Michel Loreau, David I. Forrester, Songlin Fei, Jianxiao Zhu, Zhiyao Tang, Jiangling Zhu, Pubin Hong, Chengjun Ji, Yue Shi, Haojie Su, (unknown), Jian Xiao, Shaopeng Wang, Jingyun Fang	252
9	A cohort study of the efficacy and safety of immune checkpoint inhibitors plus anlotinib versus immune checkpoint inhibitors alone as the treatment of advanced non-small cell lung cancer in the real world 2022 ·Translational Lung Cancer Research ·Yue Shi, Min Ji, Yingying Jiang, Rong Yin, Zihan Wang, Hang Li, Shuaiyu Wang, (unknown), (unknown), Zhitong Wang, Jianwei Lu, (unknown), Bo Shen, Guoren Zhou, Tracy L. Leong, Xiaohua Wang, Cheng Chen, Jifeng Feng	18
10	In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma 2022 ·Cancer Management and Research ·(unknown), (unknown), (unknown), Ji Li, (unknown), (unknown), Yue Shi, Haifeng Xu, Yongchang Zheng, Yingyi Wang, Shunda Du, Zhili Li, Xin Lü, Xinting Sang, Yilei Mao	4
11	Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway 2021 ·BMC Cancer ·Yue Shi, Chong Liu	5
12	The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1 2021 ·Frontiers in Cell and Developmental Biology ·Yue Shi, (unknown), Jianye Zhang, Jie Qi, (unknown), Mingxin Zhang, Yu Xiao, Weimin Ci	31
13	Sentinel Lymph Node Positive Rate Predicts Non-Sentinel Lymph Node Metastasis in Breast Cancer 2021 ·Journal of Surgical Research ·Xuefei Wang, (unknown), Zhichao Zuo, Qingli Zhu, (unknown), Yidong Zhou, Feng Mao, Yan Lin, Songjie Shen, Xiaohui Zhang, Xue Qin, (unknown), Xiaoying Ma, Yue Shi, (unknown)	7
14	<p>Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy</p> 2020 ·Cancer Management and Research ·(unknown), (unknown), Bao Jin, (unknown), Yue Shi, Haifeng Xu, Yongchang Zheng, (unknown), Shunda Du, Xin Lü, Xinting Sang, Yilei Mao	6
15	Efficacy and safety of urate‐lowering treatments in patients with hyperuricemia: A comprehensive network meta‐analysis of randomized controlled trials 2020 ·Journal of Clinical Pharmacy and Therapeutics ·Shanshan Sun, (unknown), Yue Shi, (unknown), (unknown)	6
16	<p>Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center</p> 2020 ·Cancer Management and Research ·(unknown), (unknown), Bao Jin, Yue Shi, (unknown), Haifeng Xu, Yongchang Zheng, (unknown), Shunda Du, Xin Lü, Yilei Mao, Xinting Sang	2
17	Increased chromosomal instability characterizes metastatic renal cell carcinoma 2020 ·Translational Oncology ·Qin Ma, Jilu Wang, Jie Qi, Peng Ding, Bao Guan, Jianye Zhang, Zhongwu Li, Hongxian Zhang, Ting Li, Yue Shi, Xuesong Li, Liqun Zhou, Ke Chen, Weimin Ci	14
18	Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice 2020 ·Nature Communications ·Shengpeng Wang, Shuang Cao, Malika Arhatte, Dahui Li, Yue Shi, (unknown), Jiong Hu, Lei Wang, Jingchen Shao, Ann Atzberger, Zheng Wang, Changhe Wang, Wei‐Jin Zang, Ingrid Fleming, Nina Wettschureck, Éric Honoré, Stefan Offermanns	107
19	shRNA-mediated silencing of TARBP2 inhibits NCI-H1299 non-small cell lung cancer cell invasion and migration via the JNK/STAT3/AKT pathway 2016 ·Molecular Medicine Reports ·Yue Shi, Duo Zuo, Xia Wang, Meng Han, Yan Wu	9
20	Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML 2008 ·Blood ·Zhihong Zeng, Yue Shi, Ismael Samudio, Rui-Yu Wang, Xiaoyang Ling, Olga Frolova, Mark J. Levis, Joshua B. Rubin, (unknown), Elihu H. Estey, Sergej Konoplev, Michael Andreeff, Marina Konopleva	397

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact